Ofrat Beyar‐Katz

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma

Chava Perry, Efrat Luttwak, R. Balaban et al. · Blood Advances · 2021 · 166 citations · Full text

Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study

Ron Ram, David Hagin, Nino Kikozashvilli et al. · Transplantation and Cellular Therapy · 2021 · 159 citations · Full text

Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells

Michael Timaner, Nitzan Letko-Khait, Ruslana Kotsofruk et al. · Cancer Research · 2018 · 102 citations · Full text

Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy

Yuval Shaked, Elizabeth Pham, Santosh Hariharan et al. · Cancer Research · 2016 · 58 citations

[18F]FDG PET-CT in patients with DLBCL treated with CAR-T cell therapy: a practical approach of reporting pre- and post-treatment studies

Dan Cohen, Efrat Luttwak, Ofrat Beyar‐Katz et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 53 citations

Positron Emission Tomography, Post-treatment Studies, Medicine +8